Literature DB >> 9268377

Distinct domains of the RelA NF-kappaB subunit are required for negative cross-talk and direct interaction with the glucocorticoid receptor.

S Wissink1, E C van Heerde, M L Schmitz, E Kalkhoven, B van der Burg, P A Baeuerle, P T van der Saag.   

Abstract

The RelA subunit of NF-kappaB and the glucocorticoid receptor mutually repress each others transcriptional activity, thus providing a mechanism for immunosuppression. Deletion analysis of the glucocorticoid receptor has shown that the DNA binding domain and the ligand binding domain are essential components for repression. Here, we show by deletions and point mutations that both the Rel homology domain and the transactivation domains of RelA are required for repression of the transcriptional activity of the glucocorticoid receptor in intact cells. However, only the Rel homology domain of RelA was found to associate with the glucocorticoid receptor in vitro. RelA mutants, not able to repress glucocorticoid receptor activity, but still able to dimerize, behaved as transdominant inhibitors of the repressive activity of wild type RelA. Furthermore, we show that the 13 S E1A protein is able to interfere with the transrepressive activity of RelA. We propose that negative cross-talk between the glucocorticoid receptor and RelA is due to direct interaction via the Rel homology domain of RelA and the DNA binding domain of the glucocorticoid receptor in combination with interference by the transactivation domains of RelA with the transcriptional activity of the glucocorticoid receptor.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9268377     DOI: 10.1074/jbc.272.35.22278

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Cytoplasmic catalytic subunit of protein kinase A mediates cross-repression by NF-kappa B and the glucocorticoid receptor.

Authors:  V Doucas; Y Shi; S Miyamoto; A West; I Verma; R M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

2.  The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain.

Authors:  R M Nissen; K R Yamamoto
Journal:  Genes Dev       Date:  2000-09-15       Impact factor: 11.361

3.  SHP limits TLR signaling, an inducible transcriptional corepressor.

Authors:  Jiyan Zhang; Beifen Shen
Journal:  Cell Mol Immunol       Date:  2011-08-22       Impact factor: 11.530

4.  Among translational effectors, p70S6k is uniquely sensitive to inhibition by glucocorticoids.

Authors:  O J Shah; S R Kimball; L S Jefferson
Journal:  Biochem J       Date:  2000-04-15       Impact factor: 3.857

5.  Cytosolic glucocorticoid receptor interaction with nuclear factor-kappa B proteins in rat liver cells.

Authors:  Christina Widén; Jan-Ake Gustafsson; Ann-Charlotte Wikström
Journal:  Biochem J       Date:  2003-07-01       Impact factor: 3.857

Review 6.  Role of the progesterone receptor (PR) in the regulation of inflammatory response pathways and aromatase in the breast.

Authors:  Carole R Mendelson; Daniel B Hardy
Journal:  J Steroid Biochem Mol Biol       Date:  2006-10-17       Impact factor: 4.292

Review 7.  Growing old with nuclear factor-kappaB.

Authors:  Charles Giardina; Andrea K Hubbard
Journal:  Cell Stress Chaperones       Date:  2002-04       Impact factor: 3.667

Review 8.  Nuclear receptors in inflammation control: repression by GR and beyond.

Authors:  Yurii Chinenov; Rebecca Gupte; Inez Rogatsky
Journal:  Mol Cell Endocrinol       Date:  2013-04-26       Impact factor: 4.102

9.  Tumour necrosis factor alpha and nuclear factor kappaB inhibit transcription of human TFF3 encoding a gastrointestinal healing peptide.

Authors:  M B Loncar; E-d Al-azzeh; P S M Sommer; M Marinovic; K Schmehl; M Kruschewski; N Blin; R Stohwasser; P Gött; T Kayademir
Journal:  Gut       Date:  2003-09       Impact factor: 23.059

10.  Transcriptional regulation of intronic calcium-activated potassium channel SK2 promoters by nuclear factor-kappa B and glucocorticoids.

Authors:  Min-Jeong Kye; Joachim Spiess; Thomas Blank
Journal:  Mol Cell Biochem       Date:  2007-03-30       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.